Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells

References

• da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204–13.
   PubMed Web of Science ®Google Scholar
• Keyser KA, Beagles KE, Kiem HP. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant. 2007;16:555–62.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Can A, Karahuseyinoglu S. Concise review. Human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007;11:2886–96.
   Google Scholar
• Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4:206–16.
   PubMed Web of Science ®Google Scholar
• Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003;48:3464–74.
   PubMed Web of Science ®Google Scholar
• Ji JF, He BP, Dheen ST, Tay SS. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells. 2004;22:415–27.
   PubMed Web of Science ®Google Scholar
• Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, . Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108:863–8.
   PubMed Web of Science ®Google Scholar
• Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20:419–27.
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20: 419–27.
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. Takeda et al (22) 2008;26:2287–99.
   Google Scholar
• Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, . Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2006;24: 81–92.
   Google Scholar
• Nekanti U, Mohanty L, Venugopal P, Balasubramanian S, Totey S, Ta M. Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res. 2010;5:244–54.
   PubMed Web of Science ®Google Scholar
• Pal R, Hanwate M, Jan M, Totey S. Phenotypic and functional comparison of optimum culture condition for upscaling of bone marrow derived mesenchymal stem cells. J Tissue Eng Regen Med. 2009;3:163–74.
   PubMed Web of Science ®Google Scholar
• Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, . Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005;106:419–27.
   PubMed Web of Science ®Google Scholar
• Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol. 2004;4:360–70.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Belperio JA, Burdick MD, Keane MP. CXC chemokines in angiogenesis relevant to chronic fibroproliferation. Curr Drug Targets Inflamm Allergy. 2005;4:23–6.
   Google Scholar
• Bièche I, Chavey C, Andrieu C, Busson M, Vacher S, Le Corre L, . CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer. 2007;14:1039–52.
   Google Scholar
• Barone F, Bombardieri M, Rosado MM, Morgan PR, Challacombe SJ, De Vita S, . CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjögren's syndrome and malt lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol. 2008;180:5130–40.
   PubMed Web of Science ®Google Scholar
• Rupprecht TA, Plate A, Adam M, Wick M, Kastenbauer S, Schmidt C, . The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6:42.
   PubMed Web of Science ®Google Scholar
• Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, . The role of IL-1a in growth and autocrine expression of proangiogenic cytokine IL-8 in HNSCC. Clin Cancer Res. 2001;7:1812–20.
   PubMed Web of Science ®Google Scholar
• Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, . CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature. 2009;460: 225–30.
   PubMed Web of Science ®Google Scholar
• Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, . Eotaxin (CCL11) induces in vivo angiogenic responses by human ccr3 endothelial cells. J Immunol. 2001;166:7571–8.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, . Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol. 1997;17: 4015–23.
   PubMed Web of Science ®Google Scholar
• McFadden C, Morgan R, Rahangdale S, Green D, Yamasaki H, Center D, . Preferential migration of T regulatory cells induced by IL-16. J Immunol. 2007;179:6439–45.
   PubMed Web of Science ®Google Scholar
• Otero K, Vecchi A, Hirsch E, Kearley J, Vermi W, Del Prete A, . Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood. 2010;116:2942–9.
   Google Scholar
• Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, . VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 2003;92:1098–106.
   PubMed Web of Science ®Google Scholar
• Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, . Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 2001;8:181–9.
   PubMed Web of Science ®Google Scholar
• Sezer O, Jakob C, Eucker J, Niemöller K, Gatz F, Wernecke K, . Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma. Eur J Haematol. 2001;66:83–8.
   PubMed Web of Science ®Google Scholar
• Sobolewski K, Małkowski A, Bańkowski E, Jaworski S. Wharton's jelly as a reservoir of peptide growth factors. Placenta. 2005;26:747–52.
   PubMed Web of Science ®Google Scholar
• Małkowski A, Sobolewski K, Jaworski S, Bańkowski E. TGF-beta binding in human Wharton's jelly. Mol Cell Biochem. 2008;311:137–43.
   Google Scholar